News & Events

News

All categories

Earnings

Press Release

All years

2019

2018

2017

2016

2015

2014

Affimed Presents Final Data for AFM13 Phase 1 Trial at ASH

December 8, 2014

Affimed Reports Financial Results for Third Quarter 2014

November 18, 2014

Affimed to Present at the Jefferies Global Healthcare Conference – London

November 12, 2014

Affimed Announces Third Quarter 2014 Financial Results Conference Call

November 11, 2014

Affimed Announces Closing of Initial Public Offering

September 17, 2014

Affimed Announces Pricing of Initial Public Offering

September 12, 2014

Affimed Secures $29.7M in Private Financing from Current and New Investors

September 2, 2014

Ferdinand Verdonck Elected to Affimed’s Supervisory Board

July 25, 2014

Affimed Files Registration Statement for Proposed Initial Public Offering

June 30, 2014

Affimed Highlights Further Data on AFM13, a Bispecific CD30/CD16A TandAb in Development to Treat Hodgkin Lymphoma, at the 2014 AACR Annual Meeting

April 10, 2014

1
2
3
4
5
6
7

Events

All

Scientific

Investors

20Mar

Innate Killer Summit 2019

March 20 - 21, 2019 (San Diego, USA)
Presenter: Martin Treder

29Mar

AACR Annual Meeting 2019

March 29 - April 3, 2019 (Georgia, USA)

Webcasts of past events
All past events

We use cookies to give you the best experience on our website. By continuing to use it, you agree with it.